Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides

Journal of Dairy Science

Volumn 96, Issue 6, 2013, Pages 3471-3487

  Han, F F ^a   Gao, Y H ^a   Luan, C ^a   Xie, Y G ^a   Liu, Y F ^a   Wang, Y Z ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Antimicrobial activity; Cytoplasmic membrane; Mechanism; Porcine lactoferricin

Indexed keywords

ANTIINFECTIVE AGENT; HEMOLYTIC AGENT; LACTOFERRIN; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BACTERIUM; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; ERYTHROCYTE; ESCHERICHIA COLI; HUMAN; MEMBRANE POTENTIAL; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; MONONUCLEAR CELL; SWINE; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; ERYTHROCYTES; ESCHERICHIA COLI; HEMOLYTIC AGENTS; HUMANS; LACTOFERRIN; LEUKOCYTES, MONONUCLEAR; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; PEPTIDES; SWINE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SUS;

EID: 84878115669     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-6104     Document Type: Article

References (39)

1. Bellamy W., Takase M., Wakabayashi H., Kawase K., Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 1992, 73:472-479.
2. Bellamy W., Wakabayashi H., Takase M., Kawase K., Shimamura S., Tomita M. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. (Berl.) 1993, 182:97-105.
3. Chen H.L., Yen C.C., Lu C.Y., Yu C.H., Chen C.M. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans. J. Agric. Food Chem. 2006, 54:3277-3282. a.
4. Chen Y., Mant C.T., Farmer S.W., Hancock R.E.W., Vasil M.L., Hodges R.S. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005, 280:12316-12329.
5. Chen Y., Vasil A.I., Rehaume L., Mant C.T., Burns J.L., Vasil M.L., Hancock R.E.W., Hodges R.S. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem. Biol. Drug Des. 2006, 67:162-173. b.
6. Cohen M.S., Britigan B.E., French M., Bean K. Preliminary observations on lactoferrin secretion in human vaginal mucus: Variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am. J. Obstet. Gynecol. 1987, 157:1122-1125.
7. Drin G., Temsamani J. Translocation of protegrin I through phospholipid membranes: Role of peptide folding. Biochim. Biophys. Acta 2002, 1559:160-170.
8. Fan Z., Cao L., He Y., Hu J., Di Z., Wu Y., Li W., Cao Z. Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus. Antimicrob. Agents Chemother. 2011, 55:5220-5229.
9. Gordon Y.J., Romanowski E.G., McDermott A.M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 2005, 30:505-515.
10. Hale J.D., Hancock R.E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 2007, 5:951-959.
11. Hancock R.E.W., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24:1551-1557.
12. Helander I.M., Nurmiaho-Lassila E.L., Ahvenainen R., Rhoades J., Roller S. Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria. Int. J. Food Microbiol. 2001, 71:235-244.
13. Heller W.T., Waring A.J., Lehrer R.I., Harroun T.A., Weiss T.M., Yang L., Huang H.W. Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry 2000, 39:139-145.
14. Je J.Y., Kim S.K. Antimicrobial action of novel chitin derivative. Biochim. Biophys. Acta 2006, 1760:104-109.
15. Jenssen H., Andersen J.H., Uhlin-Hansen L., Gutteberg T.J., Rekdal O. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res. 2004, 61:101-109.
16. Kang J.H., Lee M.K., Kim K.L., Hahm K.S. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int. J. Pept. Protein Res. 1996, 48:357-363.
17. Liu H., Du Y., Wang X., Sun L. Chitosan kills bacteria through cell membrane damage. Int. J. Food Microbiol. 2004, 95:147-155.
18. Liu Y., Han F., Xie Y., Wang Y. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Biometals 2011, 24:1069-1078.
19. Loh B., Grant C., Hancock R.E.W. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1984, 26:546-551.
20. Mangoni M.L., Papo N., Barra D., Simmaco M., Bozzi A., Di Giulio A., Rinaldi A.C. Effects of the antimicrobial peptide temporinL on cell morphology, membrane permeability and viability of Escherichia coli. Biochem. J. 2004, 380:859-865.
21. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998, 1376:391-400.
22. Moore R.A., Bates N.C., Hancock R.E. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 1986, 29:496-500.
23. Oren Z., Hong J., Shai Y. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 1997, 272:14643-14649.
24. Rathinakumar R., Walkenhorst W.F., Wimley W.C. Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: The importance of interfacial activity. J. Am. Chem. Soc. 2009, 131:7609-7617.
25. Saberwal G., Nagaraj R. Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes-Facets of their conformational features, structure-function correlations and membrane-perturbing abilities. Biochem. Biophys. Acta 1994, 1197:109-131.
26. Sang Y., Blecha F. Antimicrobial peptides and bacteriocins: Alternatives to traditional antibiotics. Anim. Health Res. Rev. 2008, 9:227-235.
27. Schiffer M., Chang C.H., Stevens F.J. The functions of tryptophan residues in membrane proteins. Protein Eng. 1992, 5:213-214.
28. Tomita M., Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 1991, 74:4137-4142.
29. Vorland L.H., Ulvatne H., Rekdal O., Svendsen J.S. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand. J. Infect. Dis. 1999, 31:467-473.
30. Wang P., Bang J.K., Kim H.J., Kim J.K., Kim Y., Shin S.Y. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1. Peptides 2009, 30:2144-2149.
31. Wiegand I., Hilpert K., Hancock R.E. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 2008, 3:163-175.
32. Wimley W.C., White S.H. Determining the membrane topology of peptides by fluorescence quenching. Biochemistry 2000, 39:161-170.
33. Wu M., Hancock R.E. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 1999, 274:29-35.
34. Wu M., Maier E., Benz R., Hancock R.E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 1999, 38:7235-7242.
35. Yamauchi K., Tomita M., Giehl T.J., Ellison R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 1993, 61:719-728.
36. Yeaman M.R., Yount N.Y., Waring A.J., Gank K.D., Kupferwasser D., Wiese R., Bayer A.S., Welch W.H. Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins. Biochim. Biophys. Acta 2007, 1768:609-619.
37. Zelezetsky I., Pag U., Sahl H.G., Tossi A. Tuning the biological properties of amphipathic α-helical antimicrobial peptides: Rational use of minimal amino acid substitutions. Peptides 2005, 26:2368-2376.
38. Zelezetsky I., Tossi A. Alpha-helical antimicrobial peptides-Using a sequence template to guide structure-activity relationship studies. Biochem. Biophys. Acta 2006, 1758(9):1436-1449.
39. Zhang L., Benz R., Hancock R.E. Influence of proline residues on the antibacterial and synergistic activities of α-helical peptides. Biochemistry 1999, 38:8102-8111.